Positive Studies Push Promising Lilly Treatment Forward

Posted: Updated:
(Image provided by Lilly.) (Image provided by Lilly.)
INDIANAPOLIS -

Indianapolis-based Eli Lilly and Co. (NYSE: LLY) has announced a key potential treatment is moving closer to market. Taltz, which is being tested for use by patients with a type of arthritis that causes inflammation in the spine, has met its targets on two late-stage studies. Lilly says the positive results clear the way for it to submit the ankylosing spondylitis treatment for U.S. regulatory approval later this year.

Vice President of Immunology Development Lotus Mallbris says "many people with AS are either untreated or still searching for an effective treatment. By using ASAS40 as the primary endpoint in our clinical development program, we hope to establish a higher treatment bar for AS patients."

ASAS40 means sufferers that were tested showed at least a 40 percent improvement in disease signs and symptoms. Lilly says those who took Taltz "demonstrated a statistically significant and clinically meaningful improvement" over the course of 16 weeks compared to those using placebo.

You can connect to more about the results by clicking here.

  • Perspectives

    • Baby Boomers Are Impacting the Building Industry

      There are currently 78 million baby boomers in the U.S., making up 25% of the population and controlling 67% ($28 trillion) of the country’s wealth, according to the Living In Place Institute. AARP says 90% of people surveyed want to remain as long as possible in their homes. The majority of those 65 and older remodel their home to make it safer and accessible. In fact, 45% of all remodeling work is being done for people over the age of 65. With this amount of data supporting...

    More

Subscribe

Name:
Company Name:
Email:
Confirm Email:
HTML
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections
INPower
Subscribe
Unsubscribe

Events



  • Most Popular Stories

    • Rendering courtesy of Two EEs Winery

      Two-EE's Winery to Adopt New Age Policy

      Two-EE's Winery in Huntington has announced it will adopt a new age policy begining in August. Our partners at WPTA-TV report the winery will no longer allow people aged under 21 to visit the establishment due to ongoing problems with unsupervised or misbehaving children. 

    • (Image courtesy of Elanco)

      Elanco Acquisition Moves Forward

      Greenfield-based Elanco Animal Health Inc. (NYSE: ELAN) is one step closer to adding to its portfolio. Shareholders of Aratana Therapeutics Inc. (Nasdaq: PETX), voted overwhelmingly in favor of proposed $245 million purchase by Elanco.

    • New Mixed-Use Development Planned for Fishers

      A new mixed-use development is coming to Fishers. Thompson Thrift Retail Group has announced the development of The Station, an office building that is part of an overall project that includes a 150-room hotel, a future retail pad along 116th Street and nearly 40 3-story townhomes.

    • (Image courtesy of the Ports of Indiana)

      Indiana Port to Host U.S. Navy Vessel Ceremony

      Port of Indiana-Burns Harbor to Host First Commissioning Ceremony in Indiana for a U.S. Navy Vessel Littoral Combat Ship Will Bear USS Indianapolis Name The Port of Indiana-Burns Harbor will host Indiana’s first U.S. Navy vessel commissioning ceremony when it commissions the USS Indianapolis littoral combat ship. 

    • (photo courtesy of the city of Bloomington)

      Bloomington Planning 'Kiln' Redevelopment

      The city of Bloomington is looking to continue the redevelopment of the former Showers Brothers Furniture Co. complex. Following the successful renovation of a former furniture factory into The Mill coworking space and incubator, the city is now planning to sell the Kiln, a one-story facility that was previously used to dry lumber before being used to fabricate furniture. The Kiln is located adjacent to The Mill and Alex Crowley, director of economic and sustainable development for...